Mojo programming language reaches 1.0 stable release after three years of API churn, ending breaking changes for production developers. An Oak Ridge National Laboratory study found Mojo GPU kernels hi ...

As hurricane season approaches its peak, two Baldwin County utility providers are encouraging customers to consider a safer ...

DOUBLECUP hides malware stages in cached PNG files, then uses ClickFix commands to deliver CountLoader variants and the ...

Automate the process of grouping thousands of search queries into coherent topics for faster, more scalable content planning.

Everyone has their toolbox of favorite programs that they install on their machines whenever they get a new one. Working with Python, I've built up my own essential toolkit. Here are the libraries and ...

*Note: For consistency, wattage ranges and starting prices listed above apply only to standby generators. Other generator types, such as portable and inverter generators, may have different power ...

STERLING, Va. — Not long after the enormous data center sprouted in Jessica Medeiros’s residential neighborhood, she began seeing black smoke. “There are times when the generators are running and … ...

Back in 2023, Chris Lattner, creator of LLVM, and his team at Modular unveiled a new language called Mojo. Its syntax resembled Python, but it compiled to machine-native code and offered memory-safety ...

With U.S. electricity demand starting to rise quickly and expected to continue rising, largely because of the power needed for data centers that process artificial intelligence, people are looking for ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...